Ralph Snyderman Challenges the Status-Quo 100 Years After Flexner.

Credit: NEJM Catalyst Mike Magee In Hcom’s most read post of 2016, we challenged the notion of “personalized medicine” as often an empty “branding exercise”, and subsequently noted a seeming disconnect between NIH supported scientific medical progress and human progress. At around the same time, Ralph Snyderman and his team at Duke published an important […]

Precise But (Not Yet) Personal

“President Obama’s new initiative to fund genetic sequencing could be a powerful tool for good in improving U.S. health care—but only if the medical establishment welcomes it.” That’s the view of Duke Chancellor Emeritus, Ralph Snyderman, MD in a recent article in The American Interest. In the article, he explains, “On January 30, 2015, President […]

Ten Years into Personalized Medicine: What We’ve Learned and What’s Next

Ralph Snyderman, M.D. ORIGINAL SOURCE Ten years ago, the sequencing of the entire human genome, along with the development of aggregate “omics” technologies began giving rise to a fundamentally new capability for the practice of medicine – the ability to predict and track disease risks on a personalized basis, to understand diseases mechanistically, and to […]

Avoiding A Health Care Bubble

Ralph Snyderman The recent report from the Department of Labor showing that the United States economy added just 69,000 jobs in May was met with surprise and disappointment and has had an immediate effect on the presidential campaign as well as the stock market. What was lost in this news, however, is that almost half of […]